Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2012-000291-42Phase 4Completed
Phase 4, randomised trial in hypogonadotropic hypogonadism (HH) comparing Testosterone undecanoate with Placebo (2 arms). Primary endpoint: Change in estimated glucose disposal rate. Started Aug 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2012-000291-42.